Topic: Alzheimer.
Destination: The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer’s and related dementias. This funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones (see Our Research Strategy for more information). We have dedicated our funding to several key areas:
Applications are reviewed throughout the year through our core programs. Check back regularly for additional joint funding opportunities with our partners in non-profits, government, and industry.
Budget:
Duration: 1 year.
Fill out the form below to receive more information: